Dr. Katz on the Oncotype DX GPS Assay in Prostate Cancer
HTML-код
- Опубликовано: 26 авг 2024
- Aaron E. Katz, MD, FACS, professor, Department of Urology, NYU Long Island School of Medicine, chairman, Department of Urology, Winthrop Hospital, NYU Langone Health’s Perlmutter Cancer Center, discusses the Oncotype DX Genomic Prostate Score assay in patients with prostate cancer.
Website: www.onclive.com
Twitter: / onclive
Facebook: / onclive
LinkedIn: / onclive